上皮间质转化与肝胆系统纤维化的研究进展

曾帅丹; 刘磊

doi:10.3969/j.issn.1001-5256.2014.07.033

上皮间质转化与肝胆系统纤维化的研究进展

DOI: 10.3969/j.issn.1001-5256.2014.07.033

曾帅丹,
刘磊

1. 遵义医学院珠海校区
2. 深圳市儿童医院普外科

详细信息

中图分类号: R575.2
计量
- 文章访问数: 2443
- HTML全文浏览量: 17
- PDF下载量: 567
- 被引次数: 0
出版历程
- 收稿日期: 2013-12-06
- 出版日期: 2014-07-20

Research progress in EMT and fibrosis of hepatobiliary system

Zhuhai Campus of Zunyi Medical College

摘要

摘要: 上皮间质转化(EMT)指的是上皮细胞在细胞因子的影响下转化成了间质细胞,从而引起组织病理性的改变。从近年的研究成果看来,EMT在各器官的纤维化中扮演了非常重要的角色,介绍了EMT在肝胆系统纤维化过程中的各种类型、各阶段的特点和发展过程,对掌握肝脏及胆管上皮细胞EMT、纤维化的发生、终止甚至逆转有重要意义。
- 上皮-间质转化 /
- 肝胆系统 /
- 纤维化 /
- 综述
Abstract: Epithelial- mesenchymal transition (EMT) , which means the transformation of epithelial cells into mesenchymal cells under the influence of cytokines, leading to pathological changes in tissues. According to recent research findings, EMT plays an important role in organ fibrosis. Various types of EMT in the fibrosis of hepatobiliary system, as well as the characteristics of each stage and the disease progression, are described, which is of great significance for understanding the development, termination, and even reversion of EMT and fibrosis of hepatic and biliary epithelial cells.
- epithelial-mesenchymal transition /
- hepatobiliary system /
- fibrosis /
- reviews

HTML全文

参考文献(36)

[1]WANG J, CHEN DF.Research on the relationship between EMT and occurrence of organ fibrosis[J].Chin J Gastroenterol Hepatol, 2012, 21 (1) :89-91. (in Chinese) 王江, 陈东风.EMT与器官纤维化发生关系的研究进展[J].胃肠病学和肝病学杂志, 2012, 21 (1) :89-91.

[2]KALLURI R, WEINBERG RA.The basics of epithelialmesenchymal transition[J].J Clin Invest, 2009, 119 (6) :1420-1428.

[3]MANI SA, GUO W, LIAO MJ, et al.The epithelialmesenchymal transition generates cells with properties of stem cells[J].Cell, 2008, 133 (4) :704-715.

[4]ZEISBERG M, NEILSON EG.Biomarkers for epithelialmesenchymal transitions[J].J Clin Invest, 2009, 119 (6) :1429-1437.

[5]CHEN XM, GUO JM, LE DH, et al.Epithelial-mesenchymal transition:an important mechanism for regulation of tumor metastasis[J].Chin J Cell Biol, 2013, 35 (9) :1367-1375. (in Chinese) 陈晓敏, 郭俊明, 乐东海, 等.上皮-间质转化:肿瘤转移的重要调控机制[J].中国细胞生物学学报, 2013, 35 (9) :1367-1375.

[6]SAVAGNER P.The epithelial-mesenchymal transition (EMT) phenomenon[J].Ann Oncol, 2010, 21 (7) :89-92.

[7]BONNOMET A, BRYSSE A, TACHSIDIS A, et al.Epithelialtomesenchymal transitions and circulating tumor cells[J].J Mammary Gland Biol Neoplasia, 2010, 15 (2) :261-273.

[8]POVERO D, BUSLETTA C, NOVO E, et al.Liver fibrosis:a dynamic and potentially reversible process[J].Histol Histopathol, 2010, 25 (8) :1075-1091.

[9]LI X, QI MH.Epithelial-mesenchymal transition in adult liver cells:a new mechanism of hepatic fibrosis[J].World Chin J Digestol, 2012, 20 (10) :811-817. (in Chinese) 李旭, 齐明华.肝内细胞上皮-间质转化:肝纤维化发生的新机制[J].世界华人消化杂志, 2012, 20 (10) :811-817.

[10]FIRRINCIELI D, BOISSAN M, CHIGNARD N.Epithelial-mesenchymal transition in the liver[J].Gastroenterol Clin Biol, 2010, 34 (10) :523-528.

[11]CHEN SL, SONG M, YANG T, et al.Profile of epithelial-mesenchymal transition during hepatic fibrogenesis and after treatment of BMPT[J].J Med Res, 2012, 41 (11) :133-137. (in Chinese) 陈少隆, 宋梅, 阳韬, 等.EMT在肝纤维化过程中的变化和骨形成蛋白-7对其影响[J].医学研究杂志, 2012, 41 (11) :133-137.

[12]RYGIEL A, ROBERTSON H, MARSHALL HL, et al.Epithelial–mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease[J].Lab Invest, 2008, 88 (2) :112-123.

[13]STRUTZ F, OKADA H, LO CW, et al.Identification and characterization of a fibroblast marker:FSP1[J].J Cell Biol, 1995, 130 (2) :393-405.

[14]HUANG S, ZHANG WY, PAN CQ, et al.Epithelial to mesenchymal phenotype transition in the liver of rats with bile duct ligation[J].J South Med Univ, 2012, 32 (2) :173-176. (in Chinese) 黄珊, 张文雍, 潘春球, 等.胆管结扎诱导的肝纤维化大鼠肝脏上皮间质表型的变化[J].南方医科大学学报, 2012, 32 (2) :173-176.

[15]LIU Y.New insights into epithelial-mesenchymal transition in kidney fibrosis[J].J Am Soc Nephrol, 2010, 21 (2) :212-222.

[16]KOJIRO T, KOUICHI M, KEIKO I, et al.Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice[J].Hepatology, 2010, 51 (3) :1027-1036.

[17]XIE G, DIEHL AM.Evidence for and against epithelial-to-mesenchymal transition in the liver[J].Am J Physiol Gastrointest Liver Physiol, 2013, 305 (12) :g881-g890.

[18]ZHANG JS, LI L.Research advances in etiology and pathogenesis of biliary atresia[J].Chin J Pediatric Surg, 2009, 30 (10) :728-731. (in Chinese) 张金山, 李龙.胆道闭锁的病因和致病机制的研究进展[J].中华小儿外科杂志, 2009, 30 (10) :728-731.

[19]HU TY.EMT in the fibrosis of bile duct in liver of patients[D].Shenyang:China Medical University, 2010. (in Chinese) 胡婷嫣.EMT机制在胆道闭锁患儿胆管纤维化改变中作用的探讨[D].沈阳:中国医科大学, 2010.

[20]DAZ R, KIM JW, HUI JJ, et al.Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis[J].Hum Pathol, 2008, 39 (1) :102-115.

[21]SUNG R, LEE SH, JI M, et al.Epithelial-mesenchymal transition-related protein expression in biliary epithelial cells associated with hepatolithiasis[J].J Gastroenterol Hepatol, 2014, 29 (2) :395-402.

[22]CHENG ZY, PENG JC, LU YH.Role of Epithelial-mesenchymal transition in the liver fibrosis[J].Chin J Clin Pharmacol Ther, 2013, 18 (8) :928-936. (in Chinese) 成志云, 彭俊纯, 吕颖慧.上皮-间充质转化对肝纤维化作用的研究进展[J].中国临床药理学与治疗学, 2013, 18 (8) :928-936.

[23]YANG Y, FAN HN, DENG Y.The role of epithelial-mesenchymal transition in gastrointestinal cancer and fibrosis[J].J Clin Hepatol, 2012, 28 (4) :312-315. (in Chinese) 杨阳, 樊海宁, 邓勇.上皮-间充质转化对消化系统肿瘤及纤维化作用的研究进展[J].临床肝胆病杂志, 2012, 28 (4) :312-315.

[24]LI BB, MING J, CHEN DG, et al.Recent progress in understanding the role of microRNAs in hepatic stellate cell biology and liver fibrosis pathogenesis[J].J Clin Hepatol, 2013, 29 (5) :385-388. (in Chinese) 李彬彬, 明健, 陈大贵, 等.microRNA在肝纤维化进程中的作用[J].临床肝胆病杂志, 2013, 29 (5) :385-388.

[25]CASTILLA MA, MORENO-BUENO G, ROMERO-PEREZ L, et al.Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma[J].J Pathol, 2011, 223 (1) :72-80.

[26]VETTORI S, GAY S, DISTLER O.Role of MicroRNAs in Fibrosis[J].Open Rheumatol J, 2012, 6:130-139.

[27]POGRIBNY IP, STARLARD DA, TRYNDYAK VP, et al.Difference in expression of hepatic miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice[J].Lab Invest, 2010, 90 (10) :1437-1446.

[28]YU JG, BAI W, LIU FY.Liver fibrosis and cirrhosis[J].Chin J Med Offic, 2004, 32 (10) :102-103. (in Chinese) 于建国, 白薇, 刘福义.肝纤维化与肝硬化[J].临床军医杂志, 2004, 32 (10) :102-103.

[29]WANG J, MA Y.Research advances in forms and reversal of liver fibrosis[J].J Med Res, 2009, 38 (3) :88-89. (in Chinese) 王瑾, 马韵.肝脏纤维化形式和逆转的研究进展[J].医学研究杂志, 2009, 38 (3) :88-89.

[30]ZHONG L, WANG X, WANG S, et al.The anti-fibrotic effect of bone morphogenic protein-7 (BMP-7) on liver fibrosis[J].Int J Med Sci, 2013, 10 (4) :441-450.

[31]BI WR, YANG CQ, SHI Q.Transforming growth factor-β1 induced epithelial-mesenchymal transition in hepatic fibrosis[J].Hepatogastroenterology, 2012, 59 (118) :1960-1963.

[32]BI WR, JIN CX, XU GT, et al.Effect of alendronate sodium on the expression of mesenchymal epithelial transition markers in mice with liver fibrosis[J].Exp Ther Med, 2013, 5 (1) :247-252.

[33]XUE ZF, WU XM, LIU M.Hepatic regeneration and the epithelial to mesenohymal transition[J].World J Gastroenterol, 2013, 19 (9) :1380-1386.

[34]OMENETTI A, YANG L, LI YX, et al.Hedgehog-mediated mesenchymal-epithelial interactions modulate hepatic response to bile duct ligation[J].Lab Invest, 2007, 87 (5) :499-514.

[35]OMENETTI A, PORRELLO A, JUNG Y, et al.Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans[J].J Clin Invest, 2008, 118 (10) :3331-3342.

[36]BATALLER R, BRENNER DA.Liver fibrosis[J].J Clin Invest, 2005, 115 (2) :209-218.

施引文献

资源附件(0)

访问统计